Compare COSM & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COSM | EQS |
|---|---|---|
| Founded | 2009 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8M | 18.9M |
| IPO Year | 2013 | N/A |
| Metric | COSM | EQS |
|---|---|---|
| Price | $0.51 | $1.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 456.0K | 25.1K |
| Earning Date | 11-17-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $59,792,819.00 | $1,377,000.00 |
| Revenue This Year | $28.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.69 | ★ 21.11 |
| 52 Week Low | $0.28 | $0.74 |
| 52 Week High | $1.32 | $2.49 |
| Indicator | COSM | EQS |
|---|---|---|
| Relative Strength Index (RSI) | 46.17 | 25.99 |
| Support Level | $0.48 | $1.27 |
| Resistance Level | $0.56 | $1.44 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 40.83 | 9.32 |
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.